Position in JBIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,550,691
+$1,109,899 QoQ
Shares Held
964,462
+19.6% QoQ
Ownership
1.52%
of shares outstanding
% of Portfolio
3.43%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
10 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in JBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GREAT POINT PARTNERS LLC holds $397,271,949 across 33 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VOR |
Vor Biopharma Inc.
|
1,700,000 | $31,297,000 | |
| 2 | ABVX |
Abivax S.A.
|
204,314 | $27,226,883 | |
| 3 | VERA |
Vera Therapeutics, Inc.
|
600,836 | $25,781,872 | |
| 4 | ZURA |
Zura Bio Ltd
|
4,215,930 | $24,873,987 | |
| 5 | ALMS |
Alumis Inc.
|
856,061 | $24,089,556 | |
| 6 | SLGL |
Sol-Gel Technologies Ltd.
|
274,363 | $20,341,272 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
425,000 | $19,992,000 | |
| 8 | ANNX |
Annexon, Inc.
|
3,500,000 | $19,985,000 |
All Filings in JBIO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,550,691 | 964,462 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,440,792 | 806,273 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,459,329 | 632,599 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,975,559 | 498,054 | Shares | Sole | 2025-08-14 | |
| 2024-03-31 AVTE | — | 887,690 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 AVTE | — | 1,037,690 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 AVTE | — | 1,091,233 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 AVTE | — | 932,158 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 AVTE | — | 755,620 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 AVTE | — | 378,522 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||